Healthcare Businesswomen's Association Celebrates Leaders in Equity and Impact for 2025
Celebrating Leaders in Healthcare: HBA’s 2025 Awards
The Healthcare Businesswomen's Association (HBA) has unveiled its esteemed recipients for the 2025 awards, recognizing individuals for their remarkable contributions in fostering gender equity within the healthcare sector. The awards will culminate in the 35th Annual Woman of the Year ceremony scheduled for May 9, 2025, in Chicago, coinciding with various global watch parties to engage audiences worldwide.
Among the distinguished honorees is Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer at Novartis U.S., who will receive the title of Woman of the Year. With over 25 years of transformative leadership in the pharmaceutical industry, she has been a driving force in the commercialization of innovative medicines and promoting access to healthcare for serious diseases. Her commitment to mentorship and sponsorship paves the way for women to excel in executive roles within the life science arena. Reshema's impactful leadership model encourages teams to approach challenges with courage, ultimately enhancing patient lives across various health conditions including oncology and immunology.
Another notable awardee is Jim Weiss, founder and chairman of Real Chemistry, honored as the Honorable Mentor. For over two decades, Jim has championed women's leadership in healthcare, transforming Real Chemistry into a global innovation leader applying AI and analytics to solve healthcare challenges. His mentorship, advisory role with the HBA over the last 15 years, and profound involvement with women-led initiatives showcase his dedication to empowering future leaders in the industry. Jim’s contributions extend beyond his professional endeavors, as he and his wife initiated the Weiss Center at Syracuse University to equip students with essential communication skills for future careers.
The Strategic Transformation Achievement Recognition (STAR) award goes to Rebecca Vermeulen, Vice President at Genentech, recognized for her significant contributions to the HBA. Rebecca’s leadership was instrumental during her term as HBA Global Board Chair, leading the organization through challenging times with her vision and empathy. An advocate for patient-centric healthcare, she also plays a crucial role in the Genentech Patient Foundation, ensuring equitable access to treatment and research solutions.
Mary Stutts, CEO of HBA, expressed pride in honoring leaders whose dedication has profoundly impacted women's advancement in healthcare. The 2025 award ceremony will not only recognize these individuals but also inspire the industry at large to embrace diversity and equality, fostering a collaborative environment where all professionals can thrive.
For those interested in joining this celebration and supporting the cause, inquiries for media passes and interviews can be directed to Hannah McComsey, Senior Manager of Communications and Media Relations, or by visiting the HBA website. Additionally, the HBA remains dedicated to empowering women in healthcare by providing resources and forums to address critical issues within the sector.
As the healthcare landscape continues to evolve, the importance of recognizing leadership that champions equity cannot be overstated. The HBA’s commitment to spotlighting the contributions of these trailblazers sets a precedent, encouraging the next generation of female leaders to aspire and strive for excellence in healthcare. Their stories serve as a powerful reminder that when women succeed, the entire industry benefits, reflecting a more inclusive future for all.